Background illustration for clinical trials search

Paid Clinical Trials Toronto

Discover 2,121 paid clinical trials in Toronto, Ontario. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Using ctDNA to Determine Therapies for Lung Cancer

for
Non Small Cell Lung Cancer, Complete Surgical Resection,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04966663

Phase 2, Recruiting

A Study of High Dose Radiation Therapy for Locally Advanced Pancreatic Cancer That Responded to Initial Chemotherapy Treatment

for
Locally Advanced Pancreatic Adenocarcinoma
Location: Toronto, Montreal
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06453486

Phase 2, Recruiting

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

for
Leukemia, Myeloid, Chronic, Myeloid Leukemia,
Location: Toronto, Cleveland OH, Baltimore MD, Augusta GA,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT04260022

Phase 1, Recruiting

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

for
Neoplasms
Location: Toronto, Ann Arbor MI, Montreal, Grand Rapids MI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06150157

Phase 1, Recruiting

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

for
Cancer, Cancer, Lung
Location: Toronto, Hamilton, Philadelphia PA, Fairfax VA,
Sponsor: Conjupro Biotherapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05948865

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

for
Chronic Graft-versus-host-disease
Location: Toronto, Hamilton, Rochester NY, Detroit MI,
Sponsor: Incyte Corporation

Sex: All

Age: 12+

Code: NCT06585774

Phase 3, Recruiting

Rituximab in Patients With Relapsed or Refractory TTP-HUS

for
Thrombotic Thrombocytopenic Purpura, Hemolytic Uremic Syndrome
Location: Toronto, Hamilton, London, Saskatoon, Vancouver
Sponsor: Hamilton Health Sciences Corporation

Sex: All

Age: 18+

Code: NCT00531089

Phase 2, Recruiting

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Toronto, Detroit MI, Columbus OH, Philadelphia PA,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05118789

Phase 1, Phase 2, Recruiting

Study Looking at Biomarkers in Ovarian Cancer

for
Gynecologic Cancer
Location: Toronto, Barrie, London, Kingston, Ottawa
Sponsor: University Health Network, Toronto

Sex: Female

Age: 18+

Code: NCT03419689

Recruiting

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

for
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG,
Location: Toronto, Hamilton, London, Syracuse NY, Gahanna OH,
Sponsor: Theralase® Technologies Inc.

Sex: All

Age: 18+

Code: NCT03945162

Phase 2, Recruiting

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

for
Prostate Cancer
Location: Toronto, Hamilton, Cleveland OH, Detroit MI, Ottawa,
Sponsor: Prostate Cancer Clinical Trials Consortium

Sex: Male

Age: 21+

Code: NCT03151629

Recruiting

Study of SGR-3515 In Participants With Advanced Solid Tumors.

for
Advanced Solid Tumor
Location: Toronto, Detroit MI, Ann Arbor MI, Columbus OH,
Sponsor: Schrödinger, Inc.

Sex: All

Age: 18+

Code: NCT06463340

Phase 1, Recruiting

Remote Monitoring of Patient Reported Outcomes to Improve the Efficacy of the Acute Phase Radiotherapy Review Process

for
Prostate Cancer, Breast Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06274892

Recruiting

A Beta-only IL-2 ImmunoTherapY Study

for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: Toronto, Detroit MI, Atlanta GA, Boca Raton FL,
Sponsor: Medicenna Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05086692

Phase 1, Phase 2, Recruiting

Monitoring and Managing Glucose Levels in People With Pancreatic Cancer

for
Pancreatic Cancer, PDAC - Pancreatic Ductal Adenocarcinoma,
Location: Toronto, Vancouver
Sponsor: British Columbia Cancer Agency

Sex: All

Age: 18+

Code: NCT05132244

Recruiting

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Toronto, Ottawa, Pittsburgh PA, Ann Arbor MI,
Sponsor: Corvus Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06561048

Phase 3, Recruiting

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Toronto, Detroit MI, Ann Arbor MI, New Haven CT,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06253130

Phase 1, Phase 2, Recruiting

Tenofovir to Prevent HBV Reactivation

for
Hepatitis B, Lymphoma, Non-Hodgkin
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT02186574

Phase 3, Recruiting

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: Toronto, Detroit MI, Philadelphia PA, New York NY,
Sponsor: BlossomHill Therapeutics

Sex: All

Age: 18+

Code: NCT06706076

Phase 1, Phase 2, Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for
Large B-cell Lymphoma
Location: Toronto, Rochester NY, Cleveland OH, Pittsburgh PA,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18+

Code: NCT06500273

Phase 2, Recruiting